Nu-Med Plus, Inc. (NUMD)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -66.38 Thousand | -38.48 Thousand | -206.83 Thousand | -414.79 Thousand | -567.34 Thousand | -467.56 Thousand |
| Net Income | -125.52 Thousand | -130.16 Thousand | -830.06 Thousand | -2 Million | -1.03 Million | -1.18 Million |
| Depreciation & Amortization | - | 10.48 Thousand | 21.37 Thousand | 24.14 Thousand | 24.45 Thousand | 14.74 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 41.8 Thousand | 35 Thousand | 200 Thousand | 961.15 Thousand | 200 Thousand | 232.06 Thousand |
| Change in working capital | 17.33 Thousand | 96.19 Thousand | 411.23 Thousand | 12.46 Thousand | 38.78 Thousand | 41.61 Thousand |
| Other non-cash items | 41.8 Thousand | -50 Thousand | -9384.00 | 596.44 Thousand | 206.25 Thousand | 432.86 Thousand |
| Investing Cash Flow | - | - | - | - | - | -5025.00 |
| Investments in PPE | - | - | - | - | - | -5025.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | -5025.00 |
| Financing Cash Flow | - | 100 Thousand | 30 Thousand | 596.22 Thousand | 406.9 Thousand | 289.06 Thousand |
| Debt repayment | - | -100 Thousand | - | -9384.00 | -10.95 Thousand | -9007.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 30 Thousand | 200 Thousand | 50 Thousand | 195 Thousand |
| Other Financing Activities | - | 200 Thousand | 30.00 | 405.61 Thousand | 417.86 Thousand | 298.07 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 897.00 | -12.55 Thousand | 27.69 Thousand | -13.77 Thousand | 30.03 Thousand | 9782.00 |
| Inventory | - | - | - | - | - | - |
| Other working capital | 16.44 Thousand | 108.75 Thousand | 383.54 Thousand | 26.23 Thousand | 8744.00 | 31.82 Thousand |
| Cash at beginning of period | 73.19 Thousand | 11.67 Thousand | 188.5 Thousand | 7079.00 | 167.51 Thousand | 351.04 Thousand |
| Cash at end of period | 6806.00 | 73.19 Thousand | 11.67 Thousand | 188.5 Thousand | 7079.00 | 167.51 Thousand |
| Capital Expenditure | - | - | - | - | - | -5025.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -66.38 Thousand | 61.52 Thousand | -176.83 Thousand | 181.42 Thousand | -160.43 Thousand | -183.53 Thousand |
| Free Cash Flow | -66.38 Thousand | -38.48 Thousand | -206.83 Thousand | -414.79 Thousand | -567.34 Thousand | -472.59 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -17.28 Thousand | -21.82 Thousand | -56.59 Thousand | -125.52 Thousand | -16.4 Thousand | -24.32 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 41.8 Thousand | 41.8 Thousand | - | - |
| Change in working capital | 14.97 Thousand | 21.37 Thousand | 10.51 Thousand | 17.33 Thousand | -2463.00 | 1248.00 |
| Other non-cash items | 1.00 | 8839.00 | 41.8 Thousand | 41.8 Thousand | -7.65 | -3500.00 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | 3500.00 |
| Accounts payables | 14.76 Thousand | 8839.00 | 1504.00 | 897.00 | -7654.00 | 552.00 |
| Inventory | - | - | - | - | - | - |
| Other working capital | 14.97 Thousand | 12.53 Thousand | 9010.00 | 16.44 Thousand | 5191.00 | -2804.00 |
| Cash at beginning of period | 6356.00 | 6806.00 | 11.08 Thousand | 73.19 Thousand | 29.95 Thousand | 53.02 Thousand |
| Cash at end of period | 4041.00 | 6356.00 | 6806.00 | 6806.00 | 11.08 Thousand | 29.95 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2315.00 | -450.00 | -4282.00 | -66.38 Thousand | -18.86 Thousand | -23.07 Thousand |
| Free Cash Flow | -2315.00 | -450.00 | -4282.00 | -66.38 Thousand | -18.86 Thousand | -23.07 Thousand |
JNJ
ESARIND
OSTIY
RITM-PA
138A
R4